αααααβααΎαSHTDY β’ OTCMKTS
add
Sinopharm Group ADR
13.37$
4 αα»αααα, 12:20:27 AM ααααβααα -5 · USD · OTCMKTS · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·α
αα·αααΈαα»α
13.34$
α
αααααααααααα
13.31$ - 13.41$
α
ααααααα½αααααΆαα
α»αααααα
10.77$ - 14.13$
ααΎαβαα»αβααΈααααΆα
65.91Β αααΈααΆα HKD
ααα ααα½αααΌαααααα
28.57Β ααΆαα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααααααΆαααΈααααΆα
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (CNY) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 145.44Β αααΈααΆα | -1.53% |
α
αααΆαααααα·ααααα·ααΆα | 6.37Β αααΈααΆα | -6.94% |
α
αααΌααα»ααα | 1.85Β αααΈααΆα | 16.88% |
ααααΆααα
αααααα»ααα | 1.27 | 18.69% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | β | β |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 4.66Β αααΈααΆα | 3.57% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 24.66% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (CNY) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 38.77Β αααΈααΆα | β |
ααααααααα»α | 418.38Β αααΈααΆα | β |
ααΆαααα½ααα»αααααΌαααα»α | 286.21Β αααΈααΆα | β |
ααΌαβααααα»α | 132.17Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 3.12Β αααΈααΆα | β |
ααααααααααΉαααααα
| 0.51 | β |
ααα
ααααααΎαααααα | 2.46% | β |
ααα
ααααααΎααΎααα»α | 4.71% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (CNY) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 1.85Β αααΈααΆα | 16.88% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | -4.97Β αααΈααΆα | 26.15% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | 781.72Β ααΆα | -19.99% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -4.04Β αααΈααΆα | -162.10% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -8.22Β αααΈααΆα | -12.59% |
ααα αΌαααΆα
αααααΆααααααα | -1.34Β αααΈααΆα | β |
α’αααΈ
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51β49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
ααΆααααααΎαα‘αΎα
2003
αααααβαααααΆα
αα»ααααα·α
100,251
